Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 26 most recent Form 4 transactions.
| Jun 12 | HALO | Halozyme Therapeutics,… | MEXER | 5,034 | — | — | +10.6% | Open the original filing on SEC.gov |
| Feb 23 | HALO | Halozyme Therapeutics,… | MEXER◆ | 7,011 | — | — | — | Open the original filing on SEC.gov |
| Feb 23 | HALO | Halozyme Therapeutics,… | FTAX | 3,782 | $70.64 | $267.2K | -7.4% | Open the original filing on SEC.gov |
| Feb 23 | HALO | Halozyme Therapeutics,… | MEXER | 7,011 | — | — | +15.8% | Open the original filing on SEC.gov |
| Feb 20 | HALO | Halozyme Therapeutics,… | MEXER◆ | 5,332 | — | — | — | Open the original filing on SEC.gov |
| Feb 20 | HALO | Halozyme Therapeutics,… | FTAX | 2,876 | $70.98 | $204.1K | -6.1% | Open the original filing on SEC.gov |
| Feb 20 | HALO | Halozyme Therapeutics,… | MEXER | 5,332 | — | — | +12.7% | Open the original filing on SEC.gov |
| Feb 16 | HALO | Halozyme Therapeutics,… | MEXER◆ | 12,016 | — | — | — | Open the original filing on SEC.gov |
| Feb 16 | HALO | Halozyme Therapeutics,… | MEXER◆ | 4,796 | — | — | — | Open the original filing on SEC.gov |
| Feb 16 | HALO | Halozyme Therapeutics,… | FTAX | 6,481 | $79.44 | $514.9K | -13.4% | Open the original filing on SEC.gov |
| Feb 16 | HALO | Halozyme Therapeutics,… | MEXER | 12,016 | — | — | +33.0% | Open the original filing on SEC.gov |
| Feb 16 | HALO | Halozyme Therapeutics,… | FTAX | 2,587 | $79.44 | $205.5K | -6.6% | Open the original filing on SEC.gov |
| Feb 16 | HALO | Halozyme Therapeutics,… | MEXER | 4,796 | — | — | +14.0% | Open the original filing on SEC.gov |
| Feb 9 | HALO | Halozyme Therapeutics,… | AGRANT◆ | 29,502 | — | — | — | Open the original filing on SEC.gov |
| Feb 9 | HALO | Halozyme Therapeutics,… | AGRANT◆ | 7,808 | — | — | — | Open the original filing on SEC.gov |
| Feb 9 | HALO | Halozyme Therapeutics,… | AGRANT◆ | 4,651 | — | — | — | Open the original filing on SEC.gov |
| Feb 9 | HALO | Halozyme Therapeutics,… | AGRANT◆ | 17,396 | — | — | — | Open the original filing on SEC.gov |
| Feb 9 | HALO | Halozyme Therapeutics,… | AGRANT◆ | 18,730 | — | — | — | Open the original filing on SEC.gov |
| Jan 3 | HALO | Halozyme Therapeutics,… | MEXER◆ | 7,611 | — | — | — | Open the original filing on SEC.gov |
| Jan 3 | HALO | Halozyme Therapeutics,… | FTAX | 4,243 | $70.31 | $298.3K | -11.0% | Open the original filing on SEC.gov |
| Jan 3 | HALO | Halozyme Therapeutics,… | MEXER | 7,611 | — | — | +24.7% | Open the original filing on SEC.gov |
| Jun 12, 2025 | HALO | Halozyme Therapeutics,… | MEXER◆ | 5,035 | — | — | — | Open the original filing on SEC.gov |
| Jun 12, 2025 | HALO | Halozyme Therapeutics,… | FTAX | 2,711 | $54.54 | $147.9K | -8.1% | Open the original filing on SEC.gov |
| Jun 12, 2025 | HALO | Halozyme Therapeutics,… | MEXER | 5,035 | — | — | +17.7% | Open the original filing on SEC.gov |